Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-06-023585
Filing Date
2006-06-05
Accepted
2006-06-05 07:45:22
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v044836_10k-a.txt 10-K/A 650104
2 v044836_ex23-1.txt EX-23.1 816
3 v044836_ex31-1.txt EX-31.1 4310
4 v044836_ex31-2.txt EX-31.2 4306
5 v044836_ex32-1.txt EX-32.1 1425
6 v044836_ex32-2.txt EX-32.2 1458
  Complete submission text file 0001144204-06-023585.txt   664114
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-13441 | Film No.: 06884771
SIC: 2836 Biological Products, (No Diagnostic Substances)